Raymond James & Associates’s Convergys CVG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-29,791
Closed -$707K 3823
2018
Q3
$707K Buy
29,791
+3,283
+12% +$81.1K ﹤0.01% 2469
2018
Q2
$648K Buy
+26,508
New +$632K ﹤0.01% 2507
2018
Q1
Sell
-20,128
Closed -$473K 3647
2017
Q4
$473K Sell
20,128
-3,074
-13% -$75.9K ﹤0.01% 2565
2017
Q3
$601K Buy
23,202
+703
+3% +$16.9K ﹤0.01% 2374
2017
Q2
$535K Buy
22,499
+3,944
+21% +$91.8K ﹤0.01% 2373
2017
Q1
$392K Sell
18,555
-265
-1% -$6.22K ﹤0.01% 2540
2016
Q4
$462K Sell
18,820
-84,423
-82% -$2.27M ﹤0.01% 2385
2016
Q3
$3.14M Buy
103,243
+168
+0.2% +$4.76K 0.01% 1187
2016
Q2
$2.58M Buy
103,075
+2,275
+2% +$61.3K 0.01% 1190
2016
Q1
$2.8M Sell
100,800
-7,399
-7% -$185K 0.01% 1104
2015
Q4
$2.69M Sell
108,199
-10,113
-9% -$255K 0.01% 1102
2015
Q3
$2.73M Sell
118,312
-53,377
-31% -$1.27M 0.01% 1051
2015
Q2
$4.38M Sell
171,689
-35,924
-17% -$870K 0.02% 878
2015
Q1
$4.75M Buy
207,613
+7,101
+4% +$150K 0.02% 767
2014
Q4
$4.08M Buy
200,512
+146,816
+273% +$2.91M 0.02% 775
2014
Q3
$957K Buy
+53,696
New +$1.04M 0.01% 1522

Other funds holding CVG

Raymond James & Associates's CVG Position: Q4 2018 in Review

Raymond James & Associates sold out of Convergys (CVG) in Q4 2018, closing a stake of 29,791 shares — an estimated $707K sold.

Raymond James & Associates first reported a position in CVG in Q3 2014 and held it in 16 quarters. The position peaked at $4.75M in Q1 2015. 2 funds tracked by Wall St. Rank hold CVG as of Q4 2018.

  • Raymond James & Associates reported no remaining Convergys position as of Q4 2018 after selling out during the quarter.
  • Raymond James & Associates sold 29,791 Convergys shares in Q4 2018, an estimated $707K.
  • Raymond James & Associates first reported a position in Convergys in Q3 2014 and held it in 16 quarters.
  • Raymond James & Associates's Convergys position peaked at $4.75M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Convergys as of Q4 2018.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.